Related Experiment Video

Updated: Jun 20, 2026

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
11:25

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins

Published on: October 4, 2017

The Sts proteins target tyrosine phosphorylated, ubiquitinated proteins within TCR signaling pathways

Nick Carpino1, Yunting Chen, Nicolas Nassar

  • 1Department of Molecular Genetics and Microbiology, Room 130, Life Sciences Building, Stony Brook University, Stony Brook, NY 11794-5222, USA. ncarpino@notes.cc.sunysb.edu

Molecular Immunology
|September 8, 2009
PubMed

Insights

Suppressor of TCR Signaling proteins (Sts-1 and Sts-2) are crucial negative regulators of T cell receptor (TCR) signaling. Their absence leads to increased levels of dual-modified proteins after TCR stimulation, revealing a novel regulatory mechanism.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • T cell receptor (TCR) signaling is vital for detecting pathogens and initiating immune responses.
  • Protein tyrosine phosphorylation and ubiquitination are key regulatory mechanisms in TCR signaling.
  • Suppressor of TCR Signaling proteins (Sts-1 and Sts-2) are known negative regulators of TCR signaling.

Purpose of the Study:

  • To investigate the role of Sts-1 and Sts-2 in regulating proteins modified by both tyrosine phosphorylation and ubiquitination downstream of the TCR.
  • To elucidate the mechanism by which Sts proteins modulate these dual-modified proteins.

Main Methods:

  • Utilized genetically engineered mice lacking Sts proteins.
  • Stimulated both naïve and activated T cells via TCR.
  • Analyzed levels of tyrosine phosphorylated and ubiquitinated proteins using biochemical assays.

Main Results:

  • T cells lacking Sts-1 and Sts-2 showed significantly elevated levels of tyrosine phosphorylated, ubiquitinated proteins after TCR stimulation.
  • The accumulation of these dually modified proteins was transient.
  • Co-receptor engagement enhanced the accumulation in activated T cells but not in naïve T cells.

Conclusions:

  • Sts-1 and Sts-2 are essential for down-modulating proteins dually modified by phosphorylation and ubiquitination following TCR signaling.
  • These findings suggest a novel regulatory pathway downstream of the TCR involving Sts proteins.

More Related Videos

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Tail-anchoring of Proteins in the ER Membrane01:45

Tail-anchoring of Proteins in the ER Membrane

Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...